News | March 14, 2026
Co-Diagnostics bags key Japanese patent, bolstering global push for rapid PCR testing
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
The trial met its primary endpoint, with patients receiving povetacicept achieving a 52.0% reduction in UPCR at Week 36
The licensed intellectual property covers methods and designs for CAR constructs engineered to function in myeloid cell populations
Merck emphasized the broader significance of the findings
Zydus has in-licensed FYB206, a proposed biosimilar to immuno-oncology therapy Keytruda (pembrolizumab), exclusively from Formycon AG for the U.S. and Canadian markets
KEYTRUDA had previously met its primary endpoint of progression-free survival in all patients
AA, a chronic immune disease, can cause extensive and unpredictable hair loss
The innovative eyedrop targets inflammation and pain following ocular surgery
The new lineup features everything from the Color Fixation and Hair Therapy ranges to the Balanced Cleansing Shampoo and Nourishment & Protection Conditioner
The agreement will see the two companies jointly develop and commercialise premium nutraceutical ingredients in advanced transdermal delivery formats
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
